Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5651
Babcock & Wilcox
BW
$1.13B
| $347K | ﹤0.01% |
54,115
-479,914
| -90% | -$3.35M |
|
5652
Golub Capital BDC
GBDC
$3.41B
| $347K | ﹤0.01% |
21,918
-194,629
| -90% | -$3.06M |
|
5653
St. Joe Company
JOE
$3.95B
| $347K | ﹤0.01% |
8,254
-16,481
| -67% | -$726K |
|
5654
V2X
VVX
$2.42B
| $347K | ﹤0.01% |
6,895
-8,726
| -56% | -$412K |
|
5655
Clearwater Paper
CLW
$348M
| $346K | ﹤0.01% |
+9,022
| New | +$287K |
|
5656
Cytosorbents Corp
CTSO
$23M
| $345K | ﹤0.01% |
42,510
-9,737
| -19% | -$79.1K |
|
|
OPFI.WS
5657
CALL
DELISTED
OppFi Inc Warrants
OPFI.WS
| $345K | ﹤0.01% |
+224,252
| New | +$350K |
|
5658
PUT
Seer Inc
SEER
$112M
| $345K | ﹤0.01% |
+10,000
| New | +$344K |
|
|
CPARU
5659
DELISTED
Catalyst Partners Acquisition Corp. Unit
CPARU
| $345K | ﹤0.01% |
35,053
-983,600
| -97% | -$9.79M |
|
|
HMLP
5660
DELISTED
HOEGH LNG PARTNERS LP
HMLP
| $345K | ﹤0.01% |
+70,274
| New | +$590K |
|
|
SNAX
5661
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
| $344K | ﹤0.01% |
4,285
+867
| +25% | +$98.9K |
|
|
SPAQ.WS
5662
CALL
DELISTED
Spartan Acquisition Corp. III Warrants, exercisable for one share of Class A Common Stock
SPAQ.WS
| $344K | ﹤0.01% |
312,470
+218,519
| +233% | +$255K |
|
5663
Rayonier Advanced Materials
RYAM
$578M
| $343K | ﹤0.01% |
45,680
-36,644
| -45% | -$252K |
|
5664
Eastern Company
EML
$155M
| $342K | ﹤0.01% |
13,577
-40,932
| -75% | -$1.14M |
|
5665
Eos Energy Enterprises
EOSE
$1.22B
| $342K | ﹤0.01% |
24,370
+1,843
| +8% | +$27.3K |
|
5666
Stride
LRN
$3.54B
| $342K | ﹤0.01% |
9,503
-17,949
| -65% | -$589K |
|
5667
CALL
Aehr Test Systems
AEHR
$3.01B
| $341K | ﹤0.01% |
+25,000
| New | +$180K |
|
|
OSG
5668
Octave Specialty Group
OSG
$204M
| $341K | ﹤0.01% |
23,829
-45,559
| -66% | -$651K |
|
|
REE
5669
CALL
DELISTED
REE Automotive
REE
| $341K | ﹤0.01% |
+2,503
| New | +$586K |
|
|
GTH
5670
DELISTED
Genetron Holdings Limited ADS
GTH
| $341K | ﹤0.01% |
8,209
-43,430
| -84% | -$2M |
|
|
ML
5671
DELISTED
MoneyLion Inc.
ML
| $341K | ﹤0.01% |
1,680
-14,245
| -89% | -$4.18M |
|
5672
CALL
Adaptive Biotechnologies
ADPT
$4.16B
| $340K | ﹤0.01% |
+10,000
| New | +$362K |
|
5673
CALL
AutoZone
AZO
$48.9B
| $340K | ﹤0.01% |
200
-1,000
| -83% | -$1.6M |
|
|
BZUN
5674
Baozun
BZUN
$164M
| $340K | ﹤0.01% |
19,403
-64,531
| -77% | -$1.59M |
|
|
IOR
5675
Income Opportunity Realty Investors
IOR
| $340K | ﹤0.01% |
28,348
+2,503
| +10% | +$30.9K |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.